A cost-effectiveness analysis of lowering residential radon levels in Sweden-Results from a modelling study.

Clicks: 453
ID: 53154
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #2 of 24 articles by views in health policy (amsterdam, netherlands)

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Residential exposure to radon is considered as the second leading cause of lung cancer after smoking. The purpose of this study was to conduct a cost-effectiveness analysis of reducing the indoor radon levels in Sweden from the current reference level of 200 Bq/m to the WHO suggested reference level of maximum 100 Bq/m.We constructed a decision-analytic cost-effectiveness model using input data from published literature and administrative records. The model compared the increase in economic costs to the health benefits of lower indoor radon-levels in a Swedish policy context. We estimated the cost per life-year and quality adjusted life year (QALY) gained and assessed the robustness of the results using both deterministic and probabilistic sensitivity analysis.Including (excluding) costs of added life years the cost per QALY for existing homes was €130,000 (€99,000). For new homes the cost per QALY including (excluding) costs of added life years was €39,000 (€25,000).The results indicate that it is not cost-effective to reduce indoor radon levels from 200 Bq/m to a maximum of 100 Bq/m in existing homes, whereas it is cost-effective for new homes.
Reference Key
svensson2018ahealth Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Svensson, Mikael;Barregård, Lars;Axelsson, Gösta;Andersson, Eva;
Journal health policy (amsterdam, netherlands)
Year 2018
DOI
S0168-8510(18)30061-7
URL
Keywords
Prevention lung cancer radon cost-effectiveness analysis

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.